CARDIOSERVER

K052883 · Datrix · DQK · Nov 1, 2005 · Cardiovascular

Device Facts

Record IDK052883
Device NameCARDIOSERVER
ApplicantDatrix
Product CodeDQK · Cardiovascular
Decision DateNov 1, 2005
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.1425
Device ClassClass 2
AttributesSoftware as a Medical Device, Pediatric, 3rd-Party Reviewed

Intended Use

The CardioServer ECG Management System software is intended to be marketed to medical professionals and for point-of-care use. The software is designed to provide a database used through out the medical community to store, display, edit and print high resolution ECG data received from devices such as electrocardiographs. The CardioServer ECG Management System software allows medical professionals responsible for the diagnosis and treatment of patients (adult and pediatric) with heart disease to: review and edit specific patient ECG data including intervals such as QT measurements and algorithm generated preliminary interpretative statements. ECG records are all associated by patient ID and other demographic data. Secure access to the database is provided.

Device Story

CardioServer ECG Management System is a software-only database for storage, display, and printing of high-resolution ECG data. Input: ECG data transferred from Datrix Cardio WiFi electrocardiograph. Operation: Software utilizes University of Glasgow ECG algorithm to provide automated interpretive analysis and serial comparison of ECGs. Output: Display of 1, 3, or 12 leads, full disclosure, user-selected strips, and physician-editable interpretations. Used in medical community/point-of-care settings by medical professionals. Healthcare providers use output to review patient ECG data, perform interval measurements via on-screen calipers, and support diagnosis/treatment of heart disease. Benefits include centralized data management, secure access, and automated preliminary interpretation to assist clinical decision-making.

Clinical Evidence

Bench testing only. Substantial equivalence demonstrated through performance, functionality, and reliability testing of the software in accordance with FDA Guidance Document: General Principles of Software Validation.

Technological Characteristics

Software-only system; Windows 2000/2003 Server environment. Connectivity: Wireless LAN, LAN, USB2. Data processing: University of Glasgow ECG Algorithm for interpretation and serial comparison. Features: 1/3/12-lead display, full disclosure, on-screen calipers, secure access, audit logging, and EHR integration via industry-standard formats.

Indications for Use

Indicated for adult and pediatric patients with heart disease. Used by medical professionals for point-of-care review, editing, and management of ECG data.

Regulatory Classification

Identification

A programmable diagnostic computer is a device that can be programmed to compute various physiologic or blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices; this device includes any associated commercially supplied programs.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ### Appendix G #### 510(k) Summary of Safety and Effectiveness for Datrix, Inc CardioServer ECG Management System #### 1. Date Summary Prepared: 9-26-2005 #### 2. SUBMITTER'S NAME AND ADDRESS: Linda Gluckman Datrix, Inc 340 State Place Escondido, CA 92029 #### 3. Contact Person: Linda Gluckman Datrix QA Manager #### 4. Device Name: | Proprietary (trade) Name: | Datrix CardioServer ECG Management System | |---------------------------|--------------------------------------------| | Common Name: | ECG Management System | | Classification Name: | Programmable Diagnostic Computer/ 870.1425 | | Product Code: | DQK | | Class: | II | #### 5. PREDICATE DEVICE: The legally marketed device/s to which equivalence is being claimed is: Quinton Pyramis ECG Management System 3303 Monte Villa Parkway Bothell, WA 98021 K032038 {1}------------------------------------------------ ## Appendix G #### 6. Device Description: CardioServer ECG Management System is a software only ECG management database that stores, displays, and prints high resolution ECG data transferred from a Datrix Cardio WiFi electrocardiograph device. All ECG records are associated by patient ID, and a final record including physician interpretation can be created. The software system analyzes data using an ECG analysis algorithm developed under direction of Dr. Peter MacFarlane, University of Glasgow (note: the same algorithm is contained in the predicate device to which equivalency is being claimed). The ECG display is able to show 1, 3, or 12 leads at once, full disclosure, user-selected strips, and interpretations editable bv physician. Hardware requirements: are Windows 2000 or 2003 Server operating system; Pentium IV, 2GHz (minimum); 512 MB RAM (minimum); 10/100 Ethernet (minimum); RAID 5 storage; 1024x768 monitor; and standard back-up technology. #### 7. Intended Use: The CardioServer ECG Management System software is intended to be marketed to medical professionals and for point-of-care use. The software is designed to work with ECG Management databases located through out the medical community that commonly store, retrieve, display, edit, and print high-resolution records of ECG data received from devices such as the Datrix Cardio WiFi electrocardiograph. The CardioServer ECG Management System software allows medical professionals responsible for the diagnosis and treatment of patients (adult and pediatric) with heart disease to do the following: - 1. Review specific patient ECG data which is available through on-screen display, printer, email, fax, or Hospital Information System (HIS) results which report by interface or other customized data bases. - 2. Analyze ECG data using calipers for measurement of various intervals. The CardioServer system does not modify the original ECG waveform information, but it does provide an automated ECG interpretive analysis of the data. The ECG data display can show 1, 3, or 12 leads at once, full disclosure, user-selected strips, interpretations (editable by physician), and lists studies using various filters (study type, patient, etc.), Resulting ECG records are {2}------------------------------------------------ ## Appendix G all associated by patient ID and include the physician interpretation. #### 8. Non-clinical Tests Used in Determination of Safety: The substantial equivalence of the Datrix ECG Management System is Demonstrated by the following non-clinical testing: - Testing to the FDA Guidance Document: General Principles of Software . Validation; Final Guidance for Industry and FDA Staff. - Testing for the performance, functionality, and reliability characteristics of . the software device followed established test procedures in a quality system. #### 9. Conclusions from Non-clinical Testing: Datrix's CardioServer ECG Management system meets the FDA Guidance Document: General Principles of Software Validation; Final Guidance for Industry and FDA Staff with acceptable results, demonstrating substantial equivalence. ### 10. Technological Comparison with Predicate: #### Both systems: - Receive ECGs via wireless LAN, LAN, USB2, and other standard . transmission modes; - Store, archive, and display ECGs; . - Export ECGs in industry standard formats to electronic health . records; - Print ECGs; ● - Utilize Windows standards; . - Are delivered as software only system; ● - Provide secure access to patient health information; . - Log all interaction with patient health information; . - Provide clinical access to ECG data across the users network; ● - Utilize the University of Glasgow ECG Algorithm for data . interpretation; - Utilize the University of Glasgow ECG Algorithm for serial . comparison of ECGs; - Allow user editing of ECG interpretation; . - Provide ECG measurements: . - Contain calipers for user edit of ECG measurements; . - Generate management reports such as departmental ECG volume. . {3}------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------4 Datrix CServer 510(k) Summary Appendix G {4}------------------------------------------------ Image /page/4/Picture/11 description: The image shows the seal of the Department of Health and Human Services (HHS). The seal features a stylized caduceus, a symbol often associated with medicine and healthcare, with three intertwined snakes around a staff. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES . USA" is arranged in a circular pattern around the caduceus. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 NOV - 1 2005 Datrix, Inc. c/o Mr. Mark Job Regulatory Technology Services, LLC 1394 25th Street NW Buffalo, MN 55313 Re: K052883 Trade Name: Datrix CardioServer ECG Management System Regulation Number: 21 CFR 870.1425 Regulation Name: Programmable Diagnostic Computer Regulatory Class: Class II (two) Product Code: DQK Dated: October 10, 2005 Received: October 13, 2005 Dear Mr. Job: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, F12A may publish further announcements concerning your device in the Federal Register. {5}------------------------------------------------ Page 2 - Mr. Mark Job Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours. Blummatfor Brand D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {6}------------------------------------------------ ## Appendix E #### Indications for Use Statement 510(k) Number (if known): Kos2883 Device Name: Datrix ECG Management System Datrix CardioServer Model: Indications for Use: The CardioServer ECG Management System software is intended to be marketed to medical professionals and for point-of-care use. The software is designed to provide a database used through out the medical community to store, display, edit and print high resolution ECG data received from devices such as electrocardiographs. The CardioServer ECG Management System software allows medical professionals responsible for the diagnosis and treatment of patients (adult and pediatric) with heart disease to: review and edit specific patient ECG data including intervals such as QT measurements and algorithm generated preliminary interpretative statements. ECG records are all associated by patient ID and other demographic data. Secure access to the database is provided. Prescription Use X Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) B. Bummuma / sion of Cardlovascular Devices k) Number 252000 1/1
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%